[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Oruka Therapeutics, Inc. Common Stock (ORKA)
Oruka Therapeutics (ORKA) stock surges after FDA clears IND application for Phase 2a trial of ORKA-001 in Psoriasis. Positive analyst ratings and increased social media engagement drive the price up.
About Oruka Therapeutics, Inc. Common Stock
Oruka Therapeutics, Inc. Common Stock (ORKA) is a healthcare stock.
Oruka Therapeutics, Inc. Common Stock uses the ticker $ORKA for trading. Listed in the Stocks and category.
Insights #
- Oruka Therapeutics, Inc. Common Stock (ORKA) social dominance is up XX% from the previous week.
- Oruka Therapeutics, Inc. Common Stock (ORKA) sentiment is up XXX% from the previous week.
- Oruka Therapeutics, Inc. Common Stock (ORKA) engagements is up XXXXXX% from the previous week.
Price: $XXXXX #
Price 24-Hour Chart Data
ORKA is trending upwards due to positive sentiment, analyst ratings, and insider activity, coupled with rising trading volume and market capitalization, supported by mentions in recent social media posts. The current price is $14.80, with a 24-hour increase of 3.65%.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| XXXX% | -XXXX% | XXXXX% |
1-Year High: $XXXXX on 2024-10-21
1-Year Low: $XXXX on 2025-04-08
AltRank: XXXXX #
AltRank 24-Hour Chart Data
Oruka Therapeutics, Inc. Common Stock (ORKA) is currently AltRank #1,160 based on combined combined social and market metrics
Daily Average: XXXXX
1 Week: XXXXX -XXX
1 Month: XXXXX -XXX
6 Months: XXXXX +205
1 Year: XXXXX -XXX
1-Year High: XXXXX on 2025-07-20
1-Year Low: XX on 2024-09-15
Galaxy Score: XX #
Galaxy Score 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1 Week: XX -X
1 Month: XX -XX
6 Months: XX -XX
1 Year: XX +11
1-Year High: XX on 2025-03-03
1-Year Low: XX on 2025-04-04
Engagements: XXXXX #
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXX +713%
1 Month: XXXXXX +260%
6 Months: XXXXXXX -XX%
1 Year: XXXXXXX +4,605%
1-Year High: XXXXXX on 2024-12-02
1-Year Low: X on 2025-05-13
| Social Network | X |
|---|---|
| Engagements | XXXXX |
Mentions: XX #
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1 Week: XX +4.80%
1 Month: XXX +166%
6 Months: XXX +109%
1 Year: XXXXX +12,856%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2024-08-20
| Social Network | X |
|---|---|
| Mentions | XX |
Creators: XX #
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning Oruka Therapeutics, Inc. Common Stock (ORKA) in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX
1 Week: XX -XX%
1 Month: XXX +163%
6 Months: XXX +364%
1 Year: XXX +9,950%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2024-08-20
Sentiment: XX% #
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +50%
1 Month: XXX% no change
6 Months: XXX% +27%
1 Year: XXX% +50%
1-Year High: XXX% on 2024-08-23
1-Year Low: XX% on 2025-01-16
Most Supportive Themes
- Positive Sentiment: (80%) Positive sentiment is fueled by positive analyst ratings, insider activity, and increased social media engagement.
Most Critical Themes
- Alternative Treatment: (19.37%) Concerns arise as alternative treatments offer similar treatments.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXX | XX% | XXX | XX% | X | X% |
| Total | XXX | XX% | XXX | XX% | X | X% |
Social Dominance: XXXXXXX% #
Social Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: XXXXXX%
1 Week: XXXXXXX% +0.00126%
1 Month: XXXXXX% -XXXXX%
6 Months: XXXXXX% -XXXXX%
1 Year: XXXXXX% +0.0059%
1-Year High: XXXXX% on 2025-06-28
1-Year Low: XXXXXX% on 2024-08-23
Market Dominance: XXXXXXXXXXXXXXXXXXXX% #
Market Dominance 24-Hour Chart Data
Current Value: XXXXXXXXXXXXXXXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2024-09-11
1-Year Low: XXXXXXX% on 2025-03-14
Market Cap: $XXXXXXXXXXX #
Market Cap 24-Hour Chart Data
Current Value: $XXXXXXXXXXX
Daily Average: $XXXXXXXXXXX
1 Week: $XXXXXXXXXXX -$2.10%
1 Month: $XXXXXXXXXXX +$29%
6 Months: $XXXXXXXXXXX +$30%
1-Year High: $XXXXXXXXXXXXX on 2024-10-21
1-Year Low: $XXXXXXXXXXX on 2025-04-08
Top assets mentioned In the posts about Oruka Therapeutics, Inc. Common Stock in the last XX hours
Sarepta Therapeutics, Inc. (SRPT) Johnson & Johnson (JNJ) Tesla, Inc. (TSLA) Dollar Tree Inc (DLTR) Bitcoin Incognito (XBI) AbbVie Inc (ABBV) United Therapeutics, Corp. (UTHR) United Therapeutics, Corp. (UTHR) Base Protocol (BASE)
Top topics mentioned In the posts about Oruka Therapeutics, Inc. Common Stock in the last XX hours
$383800ks, sqns, qqq, $srpt, spx, $jnj, $tsla, $dltr, hum, intc, pltr, $pph, $xph, $ibb, $xbi, mbx, $ucbjy, $orkas, $abbv, dx, meta, spy, msft, $glue, $cnl, put the, $bcrx, $uthr, united therapeutics corp, stocks healthcare, $csan, $base, $aura, $lsak, $sepn, $kura, $rlay, $bioa, $avir, comm, mcb, silo, $hnrg, $odvwz, $gree, $floc, $ferau, curated, $1810hk, xiaomi, nvda, googl, aa, $mltx, jnj, $nvs, $syre, cash flow, stocks, thc, hae, mob, clm, veru, $strr, $mntsw, $tcx, $ldp, uptrend, $ea, $lbgj, $hal, sol, hims, $zbio, $ben, $plse, $imnm, cuba, $cvac, $sima, $elut, $skbl, fdp, rpd, grmn, mtn, kyrgyzstani som, op, apm, $evok, celc, insp, $lung, $legn, $kids, telo, dtc, mira, amzn
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Skyrizi for $ABBV this is why I like $SYRE developing triple combination that is given less frequently and poses clear challenge to Skyrizi in IBD later this decade Also $ORKA is challenging $ABBV $NVS and $JNJ in psoriasis and related disorder with IL23-IL17 combination (3-6 month dosing )"
@bioinvestor24 on X 2025-07-27 19:46:53 UTC 3688 followers, XXX engagements
"@Biohazard3737 May be the best way to play a successful $MLTX readout is $ORKA"
@a_a_free on X 2025-07-27 15:29:20 UTC XXX followers, XXX engagements
"H.C. Wainwright reit'd $ORKA Buy/$45 after Oruka📰that the FDA had cleared its IND application for its Phase 2a trial of ORKA-001 (the company's long-acting anti-IL-23p19 antibody) in moderate-to-severe PsO called EVERLAST-A. $ABBV $PTGX - $JNJ #EDAV25 H.C. Wainwright said in its note: "This program is a randomized double-blind placebo-controlled Phase 2a trial designed to evaluate the safety and efficacy of a single dose level of ORKA-001 in moderate-to-severe psoriasis patients. EVERLAST-A will enroll approximately XX patients randomized 3:1 to receive ORKA-001 or matching placebo. The"
@Quantumup1 on X 2025-07-23 18:20:33 UTC 3534 followers, 1253 engagements
"$ORKA $SPX $GOOGL $NVDA $XIAOMI $XK $MSFT $AAPL $TSLA $VWAGY $CAR $HTZ $AMZN $ABNB $DJT $DAL $MP $REMX $THC $INTC $AMD $CRWD $IONQ $BA $CAVA $AMRK $DLTR $EQIX $SHOP $NSC $TD $TSM $TROW $HUM $GL $SQNS $LX $AUTL $CNL $GLUE $FFAI $PET $SRPT $GLD $CL $ZC $ZN $ZT $DX 🌐"
@AponiaAnalytics on X 2025-07-21 15:55:26 UTC 5006 followers, XXX engagements